Paper · 40960558

Microsatellite instability and PD-L1 expression in sarcomas: current evidence and clinical perspectives.

Ibe OE and 3 others. Med Oncol, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Microsatellite instability and PD-L1 expression in sarcomas: current evidence and clinical perspectives. Papers, record 40960558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40960558

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Microsatellite instability and PD-L1 expression in sarcomas: current evidence and clinical perspectives.; PubMed
Journal: Med Oncol; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40960558/; PubMed
DOI: https://doi.org/10.1007/s12032-025-03039-y; PubMed
The journal: https://conductscience.org/library/journal-index/9435512; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-11-05; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Ibe OE	Onyekachi Ewa
2	Ulasov I	Ilya
3	Samoylova S	Svetlana
4	Reshetov I	Igor

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
B7-H1 Antigen	Major topic
Sarcoma	Major topic
Microsatellite Instability	Major topic
Humans
Biomarkers, Tumor

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	28,515,944	Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.	J Immunother Cancer	2017	https://conductscience.org/library/papers/28515944	PubMed
2	31,494,725	Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers.	J Gastroenterol	2020	https://conductscience.org/library/papers/31494725	PubMed
3	39,989,606	PD‑1/PD‑L1 immune checkpoint in bone and soft tissue tumors (Review).	Mol Clin Oncol	2025	https://conductscience.org/library/papers/39989606	PubMed
4	31,548,600	The emerging role of epigenetic therapeutics in immuno-oncology.	Nat Rev Clin Oncol	2020	https://conductscience.org/library/papers/31548600	PubMed
5	32,582,532	Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients.	Front Oncol	2020	https://conductscience.org/library/papers/32582532	PubMed
6	34,276,259	Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas.	Pathol Oncol Res	2021	https://conductscience.org/library/papers/34276259	PubMed
7	30,173,350	Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.	Cell Mol Life Sci	2018	https://conductscience.org/library/papers/30173350	PubMed
8	37,233,406	Next generation sequencing predicting clinical effect of immunotherapy on adult rhabdomyosarcoma patient: A case report.	Medicine (Baltimore)	2023	https://conductscience.org/library/papers/37233406	PubMed
9	37,661,910	PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomas.	Immunotherapy	2023	https://conductscience.org/library/papers/37661910	PubMed
10	40,069,238	PD-1 transcriptomic landscape across cancers and implications for immune checkpoint blockade outcome.	NPJ Genom Med	2025	https://conductscience.org/library/papers/40069238	PubMed

1 to 10 of 101

See all 101 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
CD274	29,126	PubTator's text mining	https://conductscience.org/library/genes/29126

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40960558

GET https://conductscience.org/api/papers/v1/40960558/references?page=2

API reference For AI assistants